Author

Catherina L. Salanga

University of California San DiegoORCID 0009-0005-8362-1033Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:deep learning· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Tracy M. HandeliD· 3 shared Irina KufarevaiD· 2 shared Andrew TebbeniD· 1 shared Ariane L. JansmaiD· 1 shared Aura F. Celniker· 1 shared Cheyanne K. ShinniD· 1 shared Douglas P. DyeriD· 1 shared Grant M. WadmaniD· 1 shared

Activity by Year

2023-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

Tracy M. HandelORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologyJournal of Biological ChemistryPeer-reviewedSep 19, 2025

Rules of engagement: determinants of chemokine receptor activation and selectivity by CCL27 and CCL28

Mian Huang, Aura F. Celniker, Rezvan Chitsazi…·Tracy M. Handel

This study identifies N-terminal determinants of CCL27 and CCL28 receptor activation and selectivity by analyzing mutations and using AlphaFold models.

1 citation

deep learningprotein folding & dynamics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 24, 2025

Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma

Cheyanne K. Shinn, Robert Saddawi‐Konefka, Catherina L. Salanga…·Tracy M. Handel

This study shows that delivering CXCL10 into tumors enhances immune cell infiltration, activation, and anti-tumor responses, and improves the effectiveness of immunotherapy in head and neck squamous cell carcinoma.

10 citations

mouseexperimental assay

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintNov 15, 2023

Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5

John R.D. Dawson, Grant M. Wadman, Penglie Zhang…·Irina Kufareva

This study identifies molecular determinants of CCR2 and CCR5 antagonist interactions using docking and AI screening, revealing structural principles and selectivity mechanisms.

DOI 10.1101/2023.11.15.567150

humandeep learning

𝕏 PostBluesky